Rifampicin in early rheumatoid arthritis.

  title={Rifampicin in early rheumatoid arthritis.},
  author={A. A. Borg and Margaret J. Davis and P. D. Fowler and Michael F Shadforth and Peter T Dawes},
  journal={Scandinavian journal of rheumatology},
  volume={22 1},
Sixteen patients with definite or classical Rheumatoid Arthritis (RA) of less than twelve months duration were recruited into a randomised, open twelve month study comparing Rifampicin 600 mg daily (9 patients) with Hydroxychloroquine (HCQ) 400 mg daily (7 patients). Ten patients completed twelve months of treatment (4 Rifampicin, 6 HCQ). Five patients were withdrawn from the study due to lack of efficacy (1 HCQ, 4 on Rifampicin). One further patient on rifampicin was withdrawn due to… CONTINUE READING